Prot #WTX-124x2101: A Multicenter Phase I/Ib Dose Escalation Study of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Patients with Selected Advanced or Metastatic Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date3/24/23 → 3/24/26

Funding

  • Clinipace, Inc. (Prot #WTX-124x2101)
  • Werewolf Therapeutics, Inc. (Prot #WTX-124x2101)